EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Adherence to β-hydroxy-β-methylbutyrate-Enriched Oral Nutritional Supplements Enhances Survival and Nutritional Recovery in Malnourished Outpatients: Prognostic Insights

Isabel Vegas-Aguilar, Rocío Fernández-Jiménez iD, Isabel Cornejo-Pareja iD, María Del Mar Amaya-Campos, Patricia Guirado-Peláez iD, Natalia Montero-Madrid, Álvaro Vidal-Suarez iD, Maria Angeles Martín-Fontalba, Victor Simon-Frapolli iD, Francisco J Tinahones, José Manuel García-Almeida iD

Nutrients · 2025

DOI: 10.3390/nu17091601 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nutrients, 2025. Verfasst von Isabel Vegas-Aguilar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain. Hauptthemen laut MEDLINE: Valerates, Dietary Supplements, Malnutrition, Patient Compliance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Laboratories.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Disease-related malnutrition (DRM) in outpatients is associated with increased mortality and functional decline. Morphofunctional assessments, including phase angle (PA), rectus femoris cross-sectional area (RF-CSA), and handgrip strength (HGS), provide valuable prognostic insights in the ambulatory setting. Nutritional recovery programs enriched with β-hydroxy-β-methylbutyrate (HMB) offer potential benefits in improving nutritional and functional outcomes.

Objective

To evaluate the effects of a six-month nutritional recovery program combining HMB-enriched oral nutritional supplements (HMB-ONS), dietary recommendations, and exercise on survival, morphofunctional markers, and adherence in malnourished outpatients.

Methods

This retrospective observational study included 135 malnourished outpatients diagnosed using GLIM criteria. Morphofunctional assessments included PA (bioimpedance analysis), RF-CSA (nutritional ultrasound), HGS (dynamometry), and the Timed Up and Go (TUG) test. Adherence was assessed using pharmacy retrieval records and a validated questionnaire. Changes in morphofunctional markers and their association with mortality were analyzed using multivariate Cox regression models.

Results

After six months, significant improvements were observed in PA (+0.47°), RF-CSA (+0.90 cm2), HGS (+4.1 kg), and TUG (−0.93 s) (all p < 0.001). These improvements were more pronounced in the high-adherence group, which also exhibited a reduced mortality risk (HR 0.42, p < 0.05). Changes in PA and HGS were strongly associated with survival, with ΔPA showing an HR of 0.27 (95% CI: 0.15–0.50, p < 0.001) and ΔHGS showing an HR of 0.82 (95% CI: 0.75–0.89, p < 0.001).

Conclusions

A nutritional recovery program with HMB-ONS significantly improves survival and morphofunctional markers in malnourished patients, with the greatest benefits observed in those with high adherence. These findings underscore the importance of adherence-support strategies in optimizing clinical outcomes and highlight the need for further research to confirm long-term benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValeratesDietary SupplementsMalnutritionPatient ComplianceHumansMaleFemaleRetrospective StudiesAgedMiddle AgedOutpatientsPrognosisNutritional StatusHand StrengthAdministration, OralTreatment Outcome

Stichwörter der Autor:innen

dietary supplementsmalnutritionmuscle strengthnutritional statusprognosis

Substanzen

Valeratesbeta-hydroxyisovaleric acid

Autor:innen und Institutionen

  • Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain.
  • Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29010 Málaga, Spain.
  • Department of Medicine and Dermatology, Málaga University, 29016 Malaga, Spain.
  • Department of Endocrinology and Nutrition, Quironsalud Málaga Hospital, Av. Imperio Argentina, 29004 Malaga, Spain.
  • Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Rocío Fernández-Jiménez, Isabel Cornejo-Pareja, Patricia Guirado-Peláez, Álvaro Vidal-Suarez, Victor Simon-Frapolli, José Manuel García-Almeida

Förderung

  • Abbott Laboratories

Zitieren

APA

Vegas-Aguilar, I., Fernández-Jiménez, R., Cornejo-Pareja, I., Amaya-Campos, M. D. M., Guirado-Peláez, P., Montero-Madrid, N., Vidal-Suarez, Á., Martín-Fontalba, M. A., Simon-Frapolli, V., Tinahones, F. J., & García-Almeida, J. M. (2025). Adherence to β-hydroxy-β-methylbutyrate-Enriched Oral Nutritional Supplements Enhances Survival and Nutritional Recovery in Malnourished Outpatients: Prognostic Insights. Nutrients. https://doi.org/10.3390/nu17091601

Vancouver

Vegas-Aguilar I, Fernández-Jiménez R, Cornejo-Pareja I, Amaya-Campos MDM, Guirado-Peláez P, Montero-Madrid N, et al. Adherence to β-hydroxy-β-methylbutyrate-Enriched Oral Nutritional Supplements Enhances Survival and Nutritional Recovery in Malnourished Outpatients: Prognostic Insights. Nutrients. 2025. doi:10.3390/nu17091601

BibTeX
@article{VegasAguilar2025,
  author = {Vegas-Aguilar, Isabel and Fernández-Jiménez, Rocío and Cornejo-Pareja, Isabel and Amaya-Campos, María Del Mar and Guirado-Peláez, Patricia and Montero-Madrid, Natalia and Vidal-Suarez, Álvaro and Martín-Fontalba, Maria Angeles and Simon-Frapolli, Victor and Tinahones, Francisco J and García-Almeida, José Manuel},
  title = {Adherence to β-hydroxy-β-methylbutyrate-Enriched Oral Nutritional Supplements Enhances Survival and Nutritional Recovery in Malnourished Outpatients: Prognostic Insights},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17091601}
}
Kostenlos starten →